Nazareth (Belgium)/Rotterdam (The Netherlands), 11 March 2025
Invitation Fagron Capital Markets Day 2025
Fagron, the leading global player in pharmaceutical compounding, will organize its second Capital Markets Day on Thursday 10 April 2025. The event will take place at the Fagron Netherlands premises located at Venkelbaan 101, Capelle aan den IJssel, the Netherlands.
Participants will have the opportunity to attend in person or via a live video webcast, details of which will be made available in due course.
For those wishing to attend in person, please register your interest by emailing investors@fagron.com as soon as posssible. As the number of guests that we can accommodate is limited, registration will be on a ‘first-come, first-served’ basis.
Program:
Registration: 1:30PM CET
Presentations: 2PM CET – 5PM CET
A detailed agenda for the day will be made available on the Fagron website on the day.
Further information
Ignacio Artola
Global Investor Relations Leader
Tel. +34 670 385 795
Ignacio.artola@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
In the event of differences between the English translation and the Dutch original of this news release, the latter prevails.
